CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $342,898,837
- in 74 filings, $342.1M under 10b5-1 plans
Net −$342,898,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −886 | $586.14 | $519K | 43,807 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −467 | $587.37 | $274K | 43,340 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −567 | $588.38 | $334K | 42,773 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −600 | $589.40 | $354K | 42,173 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −760 | $590.36 | $449K | 41,413 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −700 | $593.13 | $415K | 40,713 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −200 | $594.11 | $119K | 40,513 |
| 2026-03-31 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 31,000 | ||
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Option exercise 10b5-1 | +10,000 | $135.42 | $1.4M | 28,876 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −40 | $581.73 | $23K | 28,836 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $583.52 | $70K | 28,716 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $585.17 | $70K | 28,596 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −437 | $586.27 | $256K | 28,159 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −860 | $587.35 | $505K | 27,299 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,487 | $588.42 | $875K | 25,812 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,196 | $589.23 | $705K | 24,616 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −1,026 | $590.36 | $606K | 23,590 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −481 | $591.26 | $284K | 23,109 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −120 | $592.12 | $71K | 22,989 |
| 2026-03-30 | EDGEMOND JAMES CFO AND TREASURER | Sale 10b5-1 | −176 | $593.68 | $104K | 22,813 |
Page 135 of 171 · 3,408 trades